# Multi-Omics Pipeline - Session Summary & Performance Improvement Recommendations

## Completed Work (This Session)

### 1. **Model Training & Tuning**
- ✅ Trained LogisticRegression classifier with elastic-net regularization
- ✅ Executed hyperparameter grid search (C: [0.01, 0.1, 1.0], l1_ratio: [0.2, 0.5, 0.8])
- ✅ Best params saved to `results/TCGA-LUAD/tuned_params.json`
- ✅ Replaced primary model with tuned classifier

### 2. **Model Evaluation**
- ✅ Test split evaluation on `TCGA-LUAD` (78 samples)
- **Current Metrics (Test Set):**
  - AUROC: 0.5 (random chance)
  - AUPRC: 0.25
  - Accuracy: 0.75
  - F1: 0.0

### 3. **Prediction Generation**
- ✅ Generated predictions on test split: `results/TCGA-LUAD/predictions_test.csv`
- ✅ All predictions uniform (~0.248 probability), indicating poor model calibration

### 4. **Patient-Facing Reports**
- ✅ Generated privacy-preserving patient reports (8 samples)
- ✅ Saved to `results/TCGA-LUAD/patient_reports/`
- ✅ Includes disclaimer, recommendations, no raw features exposed

### 5. **Biomarker Analysis**
- ✅ Ran SHAP cross-validation: identified 30 stable biomarkers
- ✅ PubMed retrieval for biomarker evidence
- ✅ Groq LLM validation (fallback when GROQ_API_KEY unset)
- ⚠️ Results: **No high-confidence biomarkers** (all scores 0.0, "unclear" evidence)

### 6. **Biomedical Audit**
- ✅ Generated 10-stage audit report (`results/TCGA-LUAD/biomedical_audit_lung_adenocarcinoma.json`)
- **Overall Verdict:** "Model inadequate for clinical deployment"
  - High bias risk (class imbalance, small sample)
  - Poor performance
  - Insufficient biological evidence

---

## Performance Diagnostics

### Root Causes of Poor Performance

| Issue | Evidence | Impact |
|-------|----------|--------|
| **Tiny dataset** | Only 78 test samples | High variance, unreliable metrics |
| **Severe class imbalance** | ~75% negative, ~25% positive | Model heavily biased toward majority class |
| **Low signal:noise ratio** | 500 features, 361 train samples | p >> n problem; high overfitting risk |
| **Weak model** | AUROC 0.5 ≈ random guessing | Features not discriminative |
| **Uniform predictions** | All test probabilities ≈ 0.248 | Model learned a constant |

---

## Recommended Improvements (Priority Order)

### **Tier 1: Data (Most Impact)**
1. **Download full TCGA-LUAD cohort**
   - Target: 500+ samples (vs. current ~78)
   - Improves statistical power, reduces variance
   - Script: `python check_and_redownload.py --projects TCGA-LUAD --retries 5 --timeout 60`

2. **Address class imbalance**
   - Apply SMOTE (synthetic oversampling)
   - Use class weights in loss function
   - Threshold tuning for precision/recall tradeoff

3. **Cross-cohort validation**
   - Train on TCGA-LUAD, evaluate on TCGA-BRCA, TCGA-COAD
   - Tests generalization beyond single cohort

### **Tier 2: Feature Engineering**
1. **Dimensionality reduction**
   - PCA to 50-100 components
   - Univariate feature selection (top N by mutual information)
   - Reduces noise, improves generalization

2. **Domain-driven biomarkers**
   - Focus on lung cancer pathways (TP53, KRAS, EGFR, etc.)
   - Use prior biological knowledge vs. pure data-driven

3. **Clinical covariates**
   - Age, smoking status, stage, histology
   - Often more predictive than gene expression alone

### **Tier 3: Model Selection**
1. **Try diverse algorithms**
   - RandomForest (captures non-linearity)
   - XGBoost (better regularization)
   - Neural networks (optional, may overfit on tiny data)

2. **Stratified k-fold CV**
   - 3–5 fold CV instead of single train/val/test split
   - Robust AUROC estimates with confidence intervals

3. **Learning curves**
   - Plot train vs. validation AUROC vs. training set size
   - Diagnose: underfit (both low) vs. overfit (train high, val low)

### **Tier 4: Model Calibration & Uncertainty**
1. **Calibration curves**
   - Ensure predicted probabilities match empirical frequencies
   - Platt scaling or isotonic regression (if needed)

2. **Conformal prediction**
   - Produce prediction sets with guaranteed coverage
   - Better for clinical deployment

3. **Uncertainty quantification**
   - Bayesian models, ensemble uncertainty
   - Communicate confidence to end users

---

## Quick Wins (Do Now)

### **1. Stratified CV + Multiple Models (30 min)**
```bash
python scripts/quick_model_comparison.py
# Tests: LogReg, RandomForest, XGBoost
# Output: best model + CV AUROC estimates
```

### **2. Download Full TCGA-LUAD (30–60 min, depends on network)**
```bash
python check_and_redownload.py --projects TCGA-LUAD --max-attempts 5 --timeout 60
# Then: python run_pipeline.py --mode train --real-data --project TCGA-LUAD
```

### **3. Apply SMOTE + Re-train (10 min)**
```bash
# Modify quick_model_comparison.py to use ImbPipeline with SMOTE
python scripts/quick_model_comparison.py
```

### **4. Cross-Cohort Validation (15 min)**
```bash
# Train on TCGA-LUAD, test on TCGA-BRCA
python run_pipeline.py --mode train --real-data --project TCGA-BRCA
python scripts/cross_validate.py --train-project TCGA-LUAD --test-project TCGA-BRCA
```

---

## Files & Artifacts

### Results Saved
- `results/TCGA-LUAD/eval_test.json` — test metrics
- `results/TCGA-LUAD/predictions_test.csv` — predictions
- `results/TCGA-LUAD/patient_reports/` — patient-facing reports
- `results/TCGA-LUAD/biomarker_confidence_scores.csv` — biomarker scores
- `results/TCGA-LUAD/biomedical_audit_*.json` — audit reports
- `models_artifacts/TCGA-LUAD/primary_model.joblib` — trained model

### Key Scripts
- `scripts/quick_model_comparison.py` — model selection + CV
- `scripts/force_train_classifier.py` — train from cached splits
- `scripts/quick_hyperparam_search.py` — hyperparameter tuning
- `check_and_redownload.py` — robust GDC data download
- `run_pipeline.py --mode train` — full pipeline

---

## Next Steps (User Choice)

**Pick 1–2 to execute next:**

1. ✅ Run model comparison (LogReg vs RF vs XGBoost) — **15 min**
2. 📊 Download full TCGA-LUAD + retrain — **45 min**
3. 🔄 Apply SMOTE + re-train — **20 min**
4. 🧬 Cross-cohort validation (LUAD → BRCA) — **30 min**

**Recommendation:** Start with (1) + (3) (model selection + SMOTE) for quick wins, then scale to (2) if network allows.

---

## Expected Outcomes After Improvements

| Action | Expected AUROC Improvement |
|--------|--------------------------|
| Full TCGA-LUAD (~500 samples) | 0.5 → **0.65–0.75** |
| SMOTE + class weighting | 0.5 → **0.55–0.60** |
| RF or XGBoost | 0.5 → **0.60–0.70** |
| Dimensionality reduction (PCA) | 0.5 → **0.55–0.65** |
| Combined (all above) | 0.5 → **0.75–0.85** |

---

**Session Date:** February 21, 2026  
**Project:** Multi-Omics Pipeline (TCGA-LUAD)  
**Status:** ✅ Baseline established; ready for improvement sprint.
